BioSpace News Archive

Menlo Park, CA, February 24, 2022 - CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors

CelerisTx, the pioneer in AI-driven proximity-inducing compound discovery, today announced the appointment of Peter T.C. Ho, M.D., Ph.D., to the Board of Directors. Dr. Ho joins the Board of CelerisTx following multiple positions as a pharma executive.

February 24, 2022

·

3 min read

Biotech Bay

Agilent to Participate at Cowen and Barclays Health Care Conferences

Agilent Technologies Inc. announced that Bob McMahon, senior vice president and chief financial officer, will participate in Q&A sessions at the Cowen 42nd Annual Health Care Conference and the Barclays Global Health Care Conference.

February 24, 2022

·

1 min read

Business

Y-mAbs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Developments

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), today reported financial results for the fourth quarter and the full year ended December 31, 2021 and provided recent corporate highlights.

February 24, 2022

·

12 min read

Business

Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2021 Financial Results

Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer and other serious diseases, reported recent business progress and fourth-quarter and full-year 2021 financial results.

February 24, 2022

·

10 min read

Business

Zynex Announces 2021 Fourth Quarter and Full Year Earnings

Zynex, Inc. an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, reported financial results for the fourth quarter and full year ended December 31, 2021.

February 24, 2022

·

9 min read

Business

Acorda Fourth Quarter/Year End 2021 Update: Webcast/Conference Call Scheduled for March 9, 2022

Acorda Therapeutics, Inc. will host a webcast/conference call in conjunction with its fourth quarter and year end 2021 update and financial results on Wednesday, March 9 at 4:30 p.m. ET.

February 24, 2022

·

5 min read

Business

Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2021 Results

Tabula Rasa HealthCare, Inc., a leading healthcare technology company advancing the safe use of medications, reported financial results for the fourth quarter and full year ended December 31, 2021.

February 24, 2022

·

17 min read

Biotech Bay

Endpoint Health Enters into Global Collaboration and Licensing Agreement with Grifols

Endpoint Health, Inc. announced that the company has entered into a global collaboration and licensing agreement with Grifols, a leading global producer of plasma-derived medicines, under which Endpoint Health will receive exclusive rights to develop and commercialize Antithrombin III in sepsis.

February 24, 2022

·

5 min read

Business

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results

United Therapeutics Corporation, a public benefit corporation, announced its financial results for the fourth quarter and year ended December 31, 2021.

February 24, 2022

·

22 min read

BioForest

NanoString to Showcase CosMx Spatial Molecular Imager at 4th Annual Spatial Genomics Summit, Feb. 28

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the commercial unveiling of the CosMx™ Spatial Molecular Imager to occur at the fourth annual virtual Spatial Genomics Summit on Monday, Feb. 28 from 8-10 a.m..

February 24, 2022

·

4 min read